Mankind Pharma (BOM:543904) Other Operating Expense : ₹49,883 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Other Operating Expense?

Mankind Pharma's Other Operating Expense for the three months ended in Mar. 2024 was ₹12,174 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹49,883 Mil.

Mankind Pharma's quarterly Other Operating Expense declined from Sep. 2023 (₹12,971 Mil) to Dec. 2023 (₹12,826 Mil) and declined from Dec. 2023 (₹12,826 Mil) to Mar. 2024 (₹12,174 Mil).

Mankind Pharma's annual Other Operating Expense increased from Mar. 2022 (₹27,748 Mil) to Mar. 2023 (₹42,611 Mil) and increased from Mar. 2023 (₹42,611 Mil) to Mar. 2024 (₹49,883 Mil).

Mankind Pharma Other Operating Expense Historical Data

The historical data trend for Mankind Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma Other Operating Expense Chart

Mankind Pharma Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Other Operating Expense

21,177.97

22,606.69

27,748.35

42,610.74

49,882.60

Mankind Pharma Quarterly Data
	Mar20	Mar21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial							10,468.29	11,911.99	12,970.77	12,825.90	12,173.94

Mankind Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹49,883 Mil.

Mankind Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Mankind Pharma (BOM:543904) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Other Operating Expense

Traded in Other Exchanges

MANKIND:India

Address

262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020

Website

https://www.mankindpharma.com

Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines